Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
CME (Berlin, Germany)
|
March 15, 2022
Peter Schlüter
MMW Fortschritte Der Medizin
|
March 9, 2016
[Not arbitrarily interpreting GOÄ]
Peter Schlüter
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
June 28, 2012
Synthesis, characterization, and application of two Al(OR(F))3 Lewis superacids
Anne Kraft, Nils Trapp, Daniel Himmel, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
March 27, 2015
The Acidity of the HBr/AlBr3 System: Stabilization of Crystalline Protonated Arenes and Their Acidity in Bromoaluminate Ionic Liquids
Franziska Scholz, Daniel Himmel, Lea Eisele, et al.
MMW Fortschritte Der Medizin
|
June 7, 2005
[What to do with malingerers?]
Peter Schlüter, Wolfgang Hasler, Volker Synatschke, et al.
Arthritis Research & Therapy
|
February 14, 2006
First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215]
Ralf H Wittenberg, Ernest Schell, Gerhard Krehan, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
CME (Berlin, Germany)
|
March 15, 2022
Peter Schlüter
MMW Fortschritte Der Medizin
|
March 9, 2016
[Not arbitrarily interpreting GOÄ]
Peter Schlüter
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
June 28, 2012
Synthesis, characterization, and application of two Al(OR(F))3 Lewis superacids
Anne Kraft, Nils Trapp, Daniel Himmel, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
March 27, 2015
The Acidity of the HBr/AlBr3 System: Stabilization of Crystalline Protonated Arenes and Their Acidity in Bromoaluminate Ionic Liquids
Franziska Scholz, Daniel Himmel, Lea Eisele, et al.
MMW Fortschritte Der Medizin
|
June 7, 2005
[What to do with malingerers?]
Peter Schlüter, Wolfgang Hasler, Volker Synatschke, et al.
Arthritis Research & Therapy
|
February 14, 2006
First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215]
Ralf H Wittenberg, Ernest Schell, Gerhard Krehan, et al.
Page
of 1